JCHOR
Journal of Current Hematology & Oncology Research

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

ISSN: Active
eISSN: 2980-0854
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Hereditary thrombophilia and recurrent pregnancy loss: is it time to reassess routine genetic testing?
Abstract
Aims: Hereditary thrombophilias are genetic conditions that increase thromboembolic risk, with heightened thrombotic potential during pregnancy due to the associated hypercoagulable state. These conditions are recognized as significant risk factors for recurrent pregnancy loss (RPL), defined as the loss of two or more consecutive pregnancies before the 20th gestational week, affecting approximately 1-2% of women of reproductive age. RPL is multifactorial, influenced by genetic, environmental, and hormonal factors, with advanced maternal age and previous pregnancy loss being prominent risk factors. While the role of hereditary thrombophilias in adverse pregnancy outcomes remains controversial, studies have reported inconsistent findings regarding their association with RPL.
Methods: This retrospective cohort study included 736 women with a history of RPL and aimed to investigate the relationship between genetic thrombophilia variants and recurrent pregnancy loss, focusing on their impact on miscarriage risk. Genetic testing using PCR panels identified common mutations such as Factor V Leiden, MTHFR, PAI-1, and prothrombin G20210A.
Results: Statistical analyses revealed no significant associations between these variants and RPL.
Conclusion: The findings suggest that, despite the prevalence of certain mutations, their contribution to miscarriage risk may be limited, underscoring the importance of selective genetic testing. This study highlights the need to optimize genetic screening practices to avoid unnecessary testing and reduce healthcare costs, supporting a more targeted approach in managing patients with RPL.

Keywords : Thrombophilia, miscarriage, FV Leiden, prothrombin G20210a

Download Article


1. Scifres CM, Macones GA. The utility of thrombophilia testing in pregnant women with thrombosis: fact or fiction? Am J Obstet Gynecol. 2008;199(4):344.e1-344.e3447. doi:10.1016/j.ajog.2008.04.051
2. ESHRE guideline ’Recurrent Pregnancy Loss’. ESHRE Early Pregnancy Guideline Development Group.Version 2.0. November, 2017.
3. Regan L, Rai R, Saravelos S, Li TC; Royal College of Obstetricians and Gynaecologists. Recurrent miscarriage green-top guideline no. 17. BJOG. 2023;130(12):e9-e39. doi:10.1111/1471-0528.17515
4. Arachchillage DRJ, Makris M. Inherited thrombophilia and pregnancy complications: should we test? Semin Thromb Hemost. 2019;45(1):50-60. doi:10.1055/s-0038-1657782
5. Shehata H, Ali A, Silva-Edge M, et al. Thrombophilia screening in women with recurrent first trimester miscarriage: is it time to stop testing?-a cohort study and systematic review of the literature. BMJ Open. 2022;12(7):e059519. doi:10.1136/bmjopen-2021-059519
6. Sotiriadis A, Vartholomatos G, Pavlou M, et al. Combined thrombophilic mutations in women with unexplained recurrent miscarriage. Am J Reprod Immunol. 2007;57(2):133-141. doi:10.1111/j.1600-0897.2006.00454.x
7. Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. Fertil Steril. 2010;93(4):1234-1243. doi:10.1016/j.fertnstert.2009.01.166
8. Bashiri A, Ratzon R, Amar S, et al. Two versus three or more primary recurrent pregnancy losses are there any differences in epidemiologic characteristics and index pregnancy outcome? J Perinat Med. 2012;40(4): 365-371. doi:10.1515/jpm-2011-0295
9. Guzel AI, Erkilinc S, Ozer I, et al. Diagnostic value of screening tests in subgroups of women with recurrent pregnancy loss. J Matern-Fetal Neonat Med. 2015;28(4):443-447. doi:10.3109/14767058.2014.920811
10. Quenby S, Booth K, Hiller L, et al. Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial. Lancet. 2023;402(10395):54-61. doi:10.1016/S0140-6736(23)00693-1
11. Wen Y, He H, Zhao K. Thrombophilic gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis. J Assist Reprod Genet. 2023;40(7):1533-1558. doi:10.1007/s10815-023-02823-x
12. Wang G, Lin Z, Wang X, et al. The association between 5, 10-methylenetetrahydrofolate reductase and the risk of unexplained recurrent pregnancy loss in China: a meta-analysis. Medicine. 2021; 100(17):e25487. doi:10.1097/MD.0000000000025487
13. Wu X, Zhao L, Zhu H, et al. Association between the MTHFR C677T polymorphism and recurrent pregnancy loss: a meta-analysis. Genet Test Mol Biomarkers. 2012;16(7):806-811. doi:10.1089/gtmb.2011.0318
14. Yang Y, Luo Y, Yuan J, et al. Association between maternal, fetal and paternal MTHFR gene C677T and A1298C polymorphisms and risk of recurrent pregnancy loss: a comprehensive evaluation. Arch Gynecol Obstet. 2016;293(6):1197-1211. doi:10.1007/s00404-015-3944-2
15. Cao Y, Xu J, Zhang Z, et al. Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis. Gene. 2013;514(2):105-111. doi:10.1016/j.gene.2012.10.091
16. Du B, Shi X, Yin C, Feng X. Polymorphisms of methalenetetrahydrofolate reductase in recurrent pregnancy loss: an overview of systematic reviews and meta-analyses. J Assist Reprod Genet. 2019;36(7):1315-1328. doi:10. 1007/s10815-019-01473-2
17. Barut MU, Bozkurt M, Kahraman M, et al. Thrombophilia and recurrent pregnancy loss: the enigma continues. Med Sci Monit. 2018;24:4288-4294. doi:10.12659/MSM.908832
18. ACOG Practice Bulletin No. 197: inherited thrombophilias in pregnancy. Obstet Gynecol. 2018;132(1):e18-e34. doi:10.1097/AOG. 0000000000002703
19. Charles J Lockwood, Inherited thrombophilias in pregnancy. In: UpToDate, Connor RF (Ed), Wolters Kluwer. Accessed on November 10, 2024.
20. Davenport WB, Kutteh WH. Inherited thrombophilias and adverse pregnancy outcomes: a review of screening patterns and recommendations. Obstet Gynecol Clin North Am. 2014;41(1):133-144. doi:10.1016/j.ogc.2013.10.005
21. Bradley LA, Palomaki GE, Bienstock J, Varga E, Scott JA. Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based review.Genet Med. 2012;14(1):39-50. doi:10. 1038/gim.0b013e31822e575b
22. Dossenbach-Glaninger A, van Trotsenburg M, Oberkanins C, Atamaniuk J. Risk for early pregnancy loss by factor XIII Val34Leu: the impact of fibrinogen concentration.J Clin Lab Anal. 2013;27(6):444-449. doi:10.1002/jcla.21626
23. Jung JH, Kim JH, Song GG, Choi SJ. Association of the F13A1 Val34Leu polymorphism and recurrent pregnancy loss: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2017;215:234-240. doi:10.1016/j.ejogrb.2017. 06.032
24. Baumann K, Beuter-Winkler P, Hackethal A, et al. Maternal factor V Leiden and prothrombin mutations do not seem to contribute to the occurrence of two or more than two consecutive miscarriages in Caucasian patients. Am J Reprod Immunol. 2013;70(6):518-521. doi:10. 1111/aji.12144
Article available in :
Volume 3, Issue 2, 2025
Page : 22-26
https://doi.org/10.51271/JCHOR-0057
Article Information
Received : 15 Ara 2024
Accepted : 16 Oca 2025
Published : 08 May 2025
Corresponding Author :

Özlem Beyler: Department of Hematology, Gazi Yaşargil Training and Research Hospital, Diyarbakır, Turkiye

[email protected]
Citation : Beyler Ö, Baş H, Balık B, et al. Hereditary thrombophilia and recurrent pregnancy loss: is it time to reassess routine genetic testing? J Curr Hematol Oncol Res. 2025;3(2):22-26.

Read: 346
Download : 243
Cited: 0
_Footer